Clinical development of IDH1 inhibitors for cancer therapy
Mehrdad Zarei, Jonathan J. Hue, Omid Hajihassani, Hallie J. Graor, Erryk Katayama, Alexander W. Loftus, David L. Bajor, Luke D. Rothermel, Ali Vaziri‐Gohar, Jordan M. Winter
Topics & Concepts
MedicineIDH1Internal medicineAdverse effectClinical trialOncologyIsocitrate dehydrogenaseHazard ratioPlaceboConfidence intervalPathologyAlternative medicineEnzymeChemistryMutationBiochemistryGeneCholangiocarcinoma and Gallbladder Cancer StudiesPancreatic and Hepatic Oncology ResearchGlioma Diagnosis and Treatment